BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4912071)

  • 1. Significance of vibriocidal antibodies with regard to immunity to cholera.
    Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR
    J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of agglutinating and vibriocidal antibodies to 2-mercaptoethanol in human cholera.
    Merritt CB; Sack RB
    J Infect Dis; 1970 May; 121():Suppl 121:25+. PubMed ID: 4912070
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of vibriocidal antibodies using agar plague techniques.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(5):708-14. PubMed ID: 5001359
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX.
    Barua D; Watanabe Y
    J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibriocidal test and its parameters.
    Ganguly R; Deb BC; Shrivastava DL
    Indian J Med Res; 1969 May; 57(5):815-22. PubMed ID: 5820430
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of Cercopithecus aethiops to cholera vibrio lipopolysaccharide and psychological stress.
    Felsenfeld O; Hill CW; Greer WE
    Trans R Soc Trop Med Hyg; 1966; 60(4):514-8. PubMed ID: 4959386
    [No Abstract]   [Full Text] [Related]  

  • 8. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):489-96. PubMed ID: 4509186
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas.
    Ahmed A; Bhattacharjee AK; Mosley WH
    J Immunol; 1970 Aug; 105(2):431-41. PubMed ID: 5433700
    [No Abstract]   [Full Text] [Related]  

  • 14. Vibriocidal antibody titrations: a comparison of three methods.
    Deb BC; Sinha R; Shrivastava DL
    Indian J Med Res; 1969 Jan; 57(1):167-74. PubMed ID: 5770835
    [No Abstract]   [Full Text] [Related]  

  • 15. Vibriocidal antibody in clinical cholera.
    McCormack WM; Chakraborty J; Rahman AS; Mosley WH
    J Infect Dis; 1969 Aug; 120(2):192-201. PubMed ID: 5387567
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of cholera cerisis inhibiting factor. 1. Isolation and specificity of the active substances from the small intestine of rabbits immunized with inactivated Vibrio cholerae].
    Morimoto T; Yamamoto M; Maruyama S; Turumizu T; Matsui S
    Yakugaku Zasshi; 1971 Dec; 91(12):1354-61. PubMed ID: 5004220
    [No Abstract]   [Full Text] [Related]  

  • 17. Vibriocidal activity, immune globulin producing cells and immune globulin levels in Theropithecus gelada after administration of a vibrio cholerae antigen.
    Felsenfeld O; Greer WE
    Immunology; 1968 Mar; 14(3):319-24. PubMed ID: 4170509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody cross-linking as a factor in immunity to cholera in infant mice.
    Bellamy JE; Knop J; Steele EJ; Chaicumpa W; Rowley D
    J Infect Dis; 1975 Aug; 132(2):181-8. PubMed ID: 1159323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae.
    Bart KJ; Huq Z; Khan M; Mosley WH
    J Infect Dis; 1970 May; 121():Suppl 121:17+. PubMed ID: 4912068
    [No Abstract]   [Full Text] [Related]  

  • 20. The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.
    Mosley WH; Woodward WE; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A; Feeley JC
    J Infect Dis; 1970 May; 121():Suppl 121:1-9. PubMed ID: 4912069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.